Characterization of maltocin P28, a novel phage tail-like bacteriocin from stenotrophomonas maltophilia

Applied and Environmental Microbiology

Volumn 79, Issue 18, 2013, Pages 5593-5600

  Liu, Jian ^a   Chen, Peng ^b   Zheng, Congyi ^a   Huang, Yu Ping ^a  

^a WUHAN UNIVERSITY   (China)

^b Hubei Provincial Corps Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RESIDUES; BACTERICIDAL ACTIVITY; GENE ORGANIZATION; OPEN READING FRAME; SDS-PAGE ANALYSIS; SEQUENCE ANALYSIS; STENOTROPHOMONAS MALTOPHILIA; STRUCTURAL PROTEINS;

AMINO ACIDS; PROTEINS; STRAIN;

GENES;

BACTERIUM; DRUG RESISTANCE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GENOME; PATHOGEN; PESTICIDE;

BACTERIAL DNA; BACTERIOCIN; PROTEINASE K; TRYPSIN;

ARTICLE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; ELECTRON MICROSCOPY; GENE ORDER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEAT; MACROMOLECULE; METABOLISM; MICROBIAL VIABILITY; MOLECULAR GENETICS; MOLECULAR WEIGHT; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; STENOTROPHOMONAS MALTOPHILIA; ULTRASTRUCTURE;

BACTERIOCINS; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASE K; GENE ORDER; HOT TEMPERATURE; MACROMOLECULAR SUBSTANCES; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MULTIGENE FAMILY; OPEN READING FRAMES; PROTEOLYSIS; SEQUENCE ANALYSIS, DNA; STENOTROPHOMONAS MALTOPHILIA; TRYPSIN;

EID: 84884217032     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01648-13     Document Type: Article

References (41)

1. Ryan RP, Monchy S, Cardinale M, Taghavi S, Crossman L, Avison MB, Berg G, Lelie D, Dow JM. 2009. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 7:514-525.
2. Brooke JS. 2012. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25:2-41.
3. Looney WJ, Narita M, Mühlemann K. 2009. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9:312-323.
4. Bin Abdulhak AA, Zimmerman V, Al Beirouti BT, Baddour LM, Tleyjeh IM. 2009. Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature. Diagn. Microbiol. Infect. Dis. 63: 330-333.
5. Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. 2008. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 27:901-906.
6. Fihman V, Le Monnier A, Corvec S, Jaureguy F, Tankovic J, Jacquier H, Carbonnelle E, Bille E, Illiaquer M, Cattoir V, Zahar JR. 2012. Stenotrophomonas maltophilia-the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J. Infect. 64:391-398.
7. Albini S, Abril C, Franchini M, Hussy D, Filioussis G. 2009. Stenotrophomonas maltophilia isolated from the airways of animals with chronic respiratory disease. Schweizer Arch. Tierheilkd. 151:323-328.
8. Winther L, Andersen RM, Baptiste KE, Aalbæḱ B, Guardabassi L. 2010. Association of Stenotrophomonas maltophilia infection with lower airway disease in the horse: a retrospective case series. Vet. J. 186:358-363.
9. Ohnishi M, Sawada T, Marumo K, Harada K, Hirose K, Shimizu A, Hayashimoto M, Sato R, Uchida N, Kato H. 2012. Antimicrobial susceptibility and genetic relatedness of bovine Stenotrophomonas maltophilia isolates from a mastitis outbreak. Lett. Appl. Microbiol. 54:572-576.
10. Alonso A, Martínez JL. 1997. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1140-1142.
11. Zhang L, Li XZ, Poole K. 2000. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob. Agents Chemother. 44:287-293.
12. Fedler KA, Biedenbach DJ, Jones RN. 2006. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn. Microbiol. Infect. Dis. 56:427-436.
13. Tan CK, Liaw SJ, Yu CJ, Teng LJ, Hsueh PR. 2008. Extensively drugresistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn. Microbiol. Infect. Dis. 60:205-210.
14. Cotter PD, Ross RP, Hill C. 2013. Bacteriocins-a viable alternative to antibiotics? Nat. Rev. Microbiol. 11:95-105.
15. Gillor O, Nigro LM, Riley MA. 2005. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials. Curr. Pharm. Des. 11:1067-1075.
16. Sang Y, Blecha F. 2008. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. Anim. Health Res. Rev. 9:227-235.
17. Dykes GA. 1995. Bacteriocins: ecological and evolutionary significance. Trends Ecol. Evol. 10:186-189.
18. Daw MA, Falkiner FR. 1996. Bacteriocins: nature, function and structure. Micron 27:467-479.
19. Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubès R, Postle K, Riley M, Slatin S, Cavard D. 2007. Colicin biology. Microbiol. Mol. Biol. Rev. 71:158-229.
20. Michel-Briand Y, Baysse C. 2002. The pyocins of Pseudomonas aeruginosa. Biochimie 84:449-510.
21. Nakayama K, Takashima K, Ishihara H, Shinomiya T, Kageyama M, Kanaya S, Ohnishi M, Murata T, Mori H, Hayashi T. 2000. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol. Microbiol. 38:213-231.
22. Nes IF, Diep DB, Holo H. 2007. Bacteriocin diversity in Streptococcus and Enterococcus. J. Bacteriol. 189:1189-1198.
23. Abriouel H, Franz CM, Ben Omar N, Gálvez A. 2011. Diversity and applications of Bacillus bacteriocins. FEMS Microbiol. Rev. 35:201-232.
24. Jabrane A, Sabri A, Compere A, Jacques P, Vandenberghe I, Beeumen JV, Thonart P. 2002. Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen. Appl. Environ. Microbiol. 68:5704-5710.
25. Strauch E, Kaspar H, Schaudinn C, Dersch P, Madela K, Gewinner C, Hertwig S, Wecke J, Appel B. 2001. Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains. Appl. Environ. Microbiol. 61:5634-5642.
26. Liu J, Liu Q, Shen P, Huang YP. 2012. Isolation and characterization of a novel filamentous phage from Stenotrophomonas maltophilia. Arch. Virol. 157:1643-1650.
27. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB. 2008. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9:R74. doi:10.1186/gb-2008-9-4-r74.
28. Lira F, Hernández A, Belda E, Sánchez MB, Moya A, Silva FJ, Martíneza JL. 2012. Whole genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain. J. Bacteriol. 194:3563-3564.
29. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
30. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
31. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. 2005. Protein identification and analysis tools on the ExPASy server, p 571-607. In Walker JM (ed), The proteomics protocols handbook. Humana Press, Clifton, NJ.
32. Milton DL, O'Toole R, Horstedt P, Wolf-Watz H. 1996. Flagellin A is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 178:1310- 1319.
33. Kovach ME, Phillips RW, Elzer PH, Roop RM, Jr, Peterson KM. 1994. pBBR1MCS: a broad-host-range cloning vector. Biotechniques 16:800- 802.
34. Hagemann M, Hasse D, Berg G. 2006. Detection of a phage genome carrying a zonula occludens like toxin gene (zot) in clinical isolates of Stenotrophomonas maltophilia. Arch. Microbiol. 185:449-458.
35. Young R. 1992. Bacteriophage lysis: mechanism and regulation. Microbiol. Rev. 56:430-481.
36. Smarda J, Benada O. 2005. Phage tail-like (high-molecular-weight) bacteriocins of Budvicia aquatica and Pragia fontium (Enterobacteriaceae). Appl. Environ. Microbiol. 71:8970-8973.
37. Haggard-Ljungquist E, Halling C, Calendar R. 1992. DNA sequences of the tail fiber genes of bacteriophage P2: evidence for horizontal transfer of tail fiber genes among unrelated bacteriophages. J. Bacteriol. 174:1462- 1477.
38. Sandmeier H. 1994. Acquisition and rearrangement of sequence motifs in the evolution of bacteriophage tail fibres. Mol. Microbiol. 12:343-350.
39. Matsui H, Sano Y, Ishihara H, Shinomiya T. 1993. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J. Bacteriol. 175:1257-1263.
40. Coenye T, Vanlaere E, Falsen E, Vandamme P. 2004. Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993. Int. J. Syst. Evol. Microbiol. 54:1235-1237.
41. Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, Li X, Li JB. 2011. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmidmediated class 1 integron. Int. J. Antimicrob. Agents 37:230-234.